Quantcast
Last updated on April 25, 2014 at 1:22 EDT

Latest Genetic disorders Stories

2014-03-04 08:32:30

CARDIFF, Calif., March 4, 2014 /PRNewswire/ -- NI Research has released the March issue of NeuroPerspective, which reviews and assesses the range of neurotherapeutics programs in development for Huntington's Disease. Huntington's is a devastating orphan neurodegenerative disorder known to affect approximately 30,000 patients in the United States, with another 150-200,000 individuals genetically at risk for the disease. Recent weeks have seen the release of Phase II trial results in HD...

2013-11-19 12:30:47

New study finds general physicians order few genetic tests, don't always discuss risks and benefits; take limited family histories ANN ARBOR, Mich., Nov. 19, 2013 /PRNewswire-USNewswire/ -- Many primary care pediatricians say they feel uncomfortable providing health care to patients with genetic disorders. Also, many do not consistently discuss all risks and benefits of genetic tests with patients, according to research published today in the American Journal of Medical Genetics....

2013-11-12 08:34:21

Approach Selectively Represses Only the Disease-Causing Gene Resulting in Statistically Significant Effects on Symptoms and Other Biomarkers of Disease in Animal Models RICHMOND, Calif., Nov. 12, 2013 /PRNewswire/ -- Sangamo BioSciences, Inc. (NASDAQ: SGMO) announced today that positive preclinical data from their joint program with Shire plc to develop a novel ZFP Therapeutic(®) approach to Huntington's disease (HD) were presented at the 2013 Annual Meeting of the Society for...

2013-10-23 04:23:16

GHENT, Belgium, October 23, 2013 /PRNewswire/ -- In a bioinformatics breakthrough, iMinds - STADIUS - KU Leuvenresearchershave successfully applied advanced artificial intelligence to enable the automated analysis of huge amounts of genetic data. Their new software suite, eXtasy, automatically generatesthe most likely cause of a given genetic disorder. The breakthrough directly impacts the treatment of millions of people with a hereditary disease. At least 5% of the...

2013-09-30 08:28:47

-- Phase 2 Clinical Trial in Huntington's Disease Slated to Begin This Year -- SEATTLE, Sept. 30, 2013 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER) announced that OMS824, its phosphodiesterase 10 (PDE10) inhibitor, has received orphan drug designation from the U.S. Food and Drug Administration for the treatment of Huntington's disease. OMS824 selectively inhibits PDE10, an enzyme expressed in areas of the brain linked to a wide range of diseases that affect cognition, including...

2013-09-24 08:31:44

Sabine to share thoughts on his courageous battle with "world's cruellest disease" CHARLOTTE, N.C., Sept. 24, 2013 /PRNewswire/ -- In his 26 years as a correspondent for NBC News covering wars, disasters, atrocities and other human suffering, Charles Sabine often put himself in harm's way. (Photo: http://photos.prnewswire.com/prnh/20130924/PH84687-a) (Photo: http://photos.prnewswire.com/prnh/20130924/PH84687-b) But the risks he sometimes felt on the job paled in comparison to...

2013-09-19 23:20:44

Reportbuyer.com just published a new market research report: Global Huntington’s Disease Therapeutics Industry London (PRWEB) September 19, 2013 This report analyzes the worldwide markets for Huntington's Disease Therapeutics in US$ Million. The report provides separate comprehensive analytics for the US, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2009 through 2018. Also, a six-year historic analysis is provided for these markets. The...

2013-08-29 16:23:03

MANHASSET, N.Y., Aug. 29, 2013 /PRNewswire-USNewswire/ -- Investigators at The Feinstein Institute for Medical Research have discovered a new way to measure the progression of Huntington's disease, using positron emission tomography (PET) to scan the brains of carriers of the gene. The findings are published in the September issue of The Journal of Clinical Investigation. (Photo: http://photos.prnewswire.com/prnh/20130829/DC71637) Huntington's disease causes the progressive...

2013-08-20 08:30:36

CHARLOTTE, N.C., Aug. 20, 2013 /PRNewswire/ -- Huntington's disease, a relatively rare and fatal inherited brain disease known as HD, could serve as a model for gaining insights into other hereditary diseases, ranging from breast cancer to dementia, that affect millions of people. (Photo: http://photos.prnewswire.com/prnh/20130820/PH66319-a ) (Logo: http://photos.prnewswire.com/prnh/20130820/PH66319LOGO-b ) "The average person has inherited six or seven genetic risks, most of them...

2013-07-23 08:31:33

Dr. Donald C. Lo of Duke University Medical Center discusses how finding a cure for Huntington's disease (HD) could affect millions of people with major neurological disorders DURHAM, N.C., July 23, 2013 /PRNewswire/ -- Huntington's disease, or HD, an inherited brain disorder that affects roughly 30,000 people in the U.S., could hold the key to finding treatments or even a cure for Alzheimer's and other major neurological disorders that affect millions of people. (Photo:...


Latest Genetic disorders Reference Libraries

44_b4e6022f2dde476f8bd4cab961972a2d
2007-12-13 19:44:51

The Munchkin is a fairly new breed of cat with a lot of controversy surrounding it. The breed is created by a mutation that causes achondroplasia, or hypochondroplasia, which results in the cats having abnormally short legs. The breed originated when a pregnant, short-legged black cat was discovered in Louisiana in 1983. One of her kittens, a tomcat, became the father of the breeding program for Munchkins. Several cat registries refuse to recognize the breed due to the controversy that...

More Articles (1 articles) »